Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
暂无分享,去创建一个
M. Beckmann | D. Niederacher | C. V. van Roeyen | H. An | M. Beckmann | S. Dominik | H. Bender | H. Schnürch | F. Picard | D. Mosny | D. Mosny | HX An | CR van Roeyen | SI Dominik | HG Schnürch